Cancer
Chemotherapy can spread breast cancer to lungs, study finds
August 9, 2017Research and Development Cancer, breast cancer, life sciences, lung cancer, pharma, pharmaceutical
Researchers at Ohio State University have discovered that, as well as forming a key part of treatment strategies to fight …
Top Ten most popular articles on Pharmafile.com this week
August 4, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, biotech, drugs, healthcare, life sciences, medicines, pharma, pharmaceuticals, top ten
Another week passes by, and the headlines have seen some shocking stories, such as the news that the UK is …
NICE greenlights Celgene pancreatic cancer drug as first-line combination treatment
August 4, 2017Medical Communications, Sales and Marketing Cancer, Celgene, NICE, Pancreatic cancer, drugs, healthcare, life sciences, medicine, pharma, pharmaceuticals
Celgene is celebrating following NICE’s announcement that it had decided to recommend the use of nab-Paclitaxel, when used in combination …
New research reveals genetic mutations in smoking-related cancers
July 27, 2017Research and Development Cancer, biotech, drugs, health, pharma, pharmaceuticals
Researchers at the Wake Forest School of Medicine in the US have made a big discovery which could help explain …
Roche antibody becomes first of its kind authorised for blood cancer
July 26, 2017Research and Development, Sales and Marketing CDF, Cancer, NICE, drugs, lymphoma, pharma, pharmaceutical Roche
NICE has announced its decision to make Roche’s Gazyvaro available via the Cancer Drugs Fund (CDF) in combination with chemotherapy …
UK underperforming in cancer care compared to Europe, according to ABPI report
July 18, 2017Research and Development ABPI, Cancer, Pancreatic cancer, biotech, heralthcare, lung cancer, ovarian cancer, pharma, pharmaceutical
According to a new report commissioned by the ABPI, the UK is continuing to fall behind in the diagnosis and …
Investigational drug found to boost treatment efficacy in paediatric brain cancer
July 12, 2017Research and Development AT/RT, Cancer, DIPG, TAK228, biotech, drugs, pharma, pharmaceutical
Researchers from the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University in Baltimore, US, have revealed in a report …
Tumour genome mapping could lead to improved outcomes, research finds
July 5, 2017Research and Development Cancer, Hi-C
A research team at the Babraham Institute in Cambridge, UK has revealed a new method to detect and monitor large-scale …
American Cancer Society and Melanoma Research Alliance join forces to bring down immunotherapy side-effects
June 29, 2017Medical Communications, Research and Development American Cancer Society, Cancer, Melanoma Research Alliance, immunotherapy
The American Cancer Society (ACS) and the Melanoma Research Alliance (MRA) have formed a research partnership to reduce the impact …
Investigational antibody boosts chemotherapy’s cancer-killing potential
June 29, 2017Research and Development CFH, Cancer, oncology, rituximab
A proof-of-concept study conducted at the Duke Cancer Institute (DCI) in North Carolina has shown that an investigational antibody has …
Gold rods used to ‘break cancer’s legs’
June 28, 2017Research and Development Cancer, Georgia Tech, nanorods
A study emerging from Georgia Tech has found a new way of stopping metastasising cancer’s spread through the body. The …
New research unlocks the key to slowing cancer metastasis
June 22, 2017Research and Development Cancer, metastasis
Stemming from a theory she developed as a sophomore at John Hopkins University in Maryland, Hasini Jayatilaka and a team …
Cambridge start-up secures £40 million to trial innovative cancer drugs
June 16, 2017Medical Communications, Research and Development, Sales and Marketing Bicycle Therapeutics, Cambridge, Cancer
Bicycle Therapeutics, a biotech start-up based in Cambridge, UK, has just raised £40 million from a range of investors including …
BMS’ Opdivo scores eighth approval in Europe for bladder cancer
June 5, 2017Research and Development, Sales and Marketing Bristol-Myers Squibb, Cancer, Europe, European Commission, bladder cancer, immunotherapy
Bristol-Myers Squibb has announced that its flagship immunotherapy treatment Opdivo (nivolumab) has secured its eighth approval in Europe as the …
Latest prostate cancer research could provide boost for J&J
June 5, 2017Research and Development, Sales and Marketing CRUK, Cancer, Johnson & Johnson, prostate cancer
Research funded by Cancer Research UK has found that abiraterone added to hormone therapy improved survival by over a third …
Latest content
AstraZeneca’s Trixeo approved in EU for asthma
ESTEVE CDMO adds $17.5m to Illinois expansion
